However, few randomized controlled studies have reported the relationship between SGLT-2 and AF, and therefore, reports of detailed prognostic characteristics such as change of AF burden and rhythm control other than the incidence of AF are rare. This evidence concerns the gene SLC5A2 and atrial fibrillation.